Zobrazeno 1 - 10
of 198
pro vyhledávání: '"K. Hacene"'
Autor:
J. Wafflart, Jean-Marc Riedinger, G. Ricolleau, K. Hacene, N. Eche, I. Dalifard, J. P. Basuyau, H. Larbre, M. F. Pichon, C. Touzery
Publikováno v:
Oncologie. 8:132-138
Cette etude multicentrique de la cinetique de CA-125 sous chimiotherapie d’induction a ete realisee sur une population de 631 patientes porteuses d’un cancer ovarien epithelial (stade FIGOI a IV). Le recul median (extremes) est de37 mois (2-222 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e61a80a8c43ce580dfe04d193e4e4780
https://doi.org/10.1007/s10269-006-0348-8
https://doi.org/10.1007/s10269-006-0348-8
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 19:208-214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::849a84ab9287cdf995cf5ded94d487a4
https://doi.org/10.1016/s0923-2532(04)00065-1
https://doi.org/10.1016/s0923-2532(04)00065-1
Publikováno v:
The International Journal of Biological Markers. 19:14-22
Purpose To determine the clinical correlations and prognostic value of serum HER-2 (sHER-2) before and after primary breast cancer treatment. Methods sHER-2 from 701 consecutive patients with stage I-III tumors (median follow-up 7.7 years) was assaye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274e6dd65a7f968b47c19ab9008f18d0
https://doi.org/10.5301/jbm.2008.1233
https://doi.org/10.5301/jbm.2008.1233
Autor:
M Tubiana-Hulin, Frédérique Spyratos, Michel Vidaud, Rosette Lidereau, K Hacene, Christophe Andrieu, Peter Onody, Ivan Bièche, Sengül Tozlu, Florence Lerebours
Publikováno v:
Cancer Letters. 174:173-178
We examined the relation between ERBB2 gene expression (as determined by a real-time quantitative RT-PCR assay) and the response to adjuvant tamoxifen therapy in a well-defined cohort of 125 ER α-positive postmenopausal patients with breast cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398311a09453570c5e92a64dcf735610
https://doi.org/10.1016/s0304-3835(01)00696-6
https://doi.org/10.1016/s0304-3835(01)00696-6
Autor:
Jocelyne Jacquemier, Viviane Le Doussal, F. Collin, Philippe Terrier, Marie-Odile Vilain, K. Hacene, Jean-Michel Coindre, Xavier Sastre-Garau, Gérard Bertrand, M Fiche, Louis Guillou, Françoise Bonichon, Martine Trassard, Dominique Ranchère, Nguyen Binh Bui
Publikováno v:
Journal of Clinical Oncology. 19:525-534
PURPOSE: To identify most significant and therapeutically relevant prognostic factors in adults with localized primary synovial sarcomas (SS) and to confirm the usefulness of the French Federation of Cancer Centers (FNCLCC) grading system, the progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162efabc56e81bdd03df315912058ef6
https://doi.org/10.1200/jco.2001.19.2.525
https://doi.org/10.1200/jco.2001.19.2.525
Publikováno v:
Tumor Biology. 22:27-35
Patients with head and neck tumours (HNT) have a high risk of early locoregional relapse that is difficult to diagnose. This study evaluated the usefulness of the serum Cyfra 21-1 assay compared to squamous cell carcinoma antigen (SCC) assay for moni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::115fbc56eb2c5adf9097f61347dfecd3
https://doi.org/10.1159/000030152
https://doi.org/10.1159/000030152
Publikováno v:
British Journal of Cancer
Urokinase-type plasminogen activator (uPA) is a potentially important prognostic factor in breast cancer for identifying patients at high risk of recurrence. This retrospective study assessed two enzyme-linked immunosorbent assay (ELISA) methods meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb54c6f6946ee7ee97585ba6c3ba2541
https://doi.org/10.1038/bjc.1998.246
https://doi.org/10.1038/bjc.1998.246
Autor:
A. Leroux, Viviane Le Doussal, Philippe Terrier, Françoise Bonichon, Geneviève Contesso, Nguyen Binh Bui, K. Hacene, Jean-Michel Coindre, Anne-Marie Mandard, F. Collin
Publikováno v:
Cancer. 77:1823-1830
BACKGROUND The purpose of this study was to determine the independent prognostic variables in a well documented subset of 216 patients with localized primary malignant fibrous histiocytomas (MFH). METHODS Between the years 1980 and 1989, 216 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e174b6818836bf5abd7c7678faeed79
https://doi.org/10.1002/(sici)1097-0142(19960501)77:9<1823::aid-cncr10>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19960501)77:9<1823::aid-cncr10>3.0.co
Autor:
W. Gullickl, F. Beuvon, Pierre Pouillart, Ivan Bièche, C. Pallud, K. Hacene, Susy Scholl, Rosette Lidereau, M.H. Champème
Publikováno v:
The Breast. 5:21-30
A multitude of clinical, pathological and biological parameters have been reliably associated with prognosis in breast cancer patients. Recently much interest has been engendered by multifactorial computing methods attempting to produce higher progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ce967dec0d80fea69da799e12570121
https://doi.org/10.1016/s0960-9776(96)90045-4
https://doi.org/10.1016/s0960-9776(96)90045-4
Publikováno v:
Histopathology. 23:249-256
Expression of pS2 was studied by immunocytochemistry in normal breast tissue (n = 20), benign tumours (n = 9) and 145 breast cancers representative of the different histological types. pS2 immunostaining was scored as negative (D1 = 0-5% stained cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bc270b5771ca17308c73185b67c17a
https://doi.org/10.1111/j.1365-2559.1993.tb01197.x
https://doi.org/10.1111/j.1365-2559.1993.tb01197.x